A patent application in Turkey records who developed RibXcar
In October 2024, two Turkish applicants unconnected to the team filed a patent application for a waist-narrowing method. In its background section, describing the state of the art, they write that «Manzaneda and colleagues developed and introduced the RibXCar technique, the most up-to-date version of rib shaping procedures described to date».
What the document is
| Field | Value |
|---|---|
| Publication number | TR2024013248A2 |
| Title | Aesthetic Waist Slimming Method Through Rib Shaping |
| Applicants | Yildirim Erdem · Ersöz Hasan (Turkey) |
| Filed | 2 October 2024 |
| Published | 21 October 2024 |
| Status | code A2: application published, not granted or examined |
It can be consulted on Google Patents.
What it says about the technique's authorship
The application devotes its background section to how waist procedures evolved. It places rib removal first, then remodeling techniques «as described by Dr. Kudzaev in 2020 and subsequently developed and modified», and arrives at RibXcar:
«To this end, Manzaneda and colleagues developed and introduced the RibXCar technique, the most up-to-date version of rib shaping procedures described to date, in their article published in December 2023. The RibXCar technique involves controlled fractures of the ribs without any stitches or incisions.»
The article referred to is the foundational study published in PRS Global Open on 20 December 2023.
Why a document like this carries weight
Much of what is published about a surgical technique is written by those who practise it. This document is not: it was drafted by third parties, in another country, for their own patent filing.
And the acknowledgement runs against the interest of whoever wrote it: to claim an improvement you must first admit what already existed and whose it was. That is precisely the passage they wrote.
What this document does NOT mean
Precision matters here, because a text like this can be over-read in either direction.
It is not a ruling on priority. A patent office does not certify who invented what by publishing an application; it publishes what the applicant states. It is a dated third-party acknowledgement, not a decision.
It is not granted. Code A2 means an application published without examination. Its content has not been validated by any authority.
It is not a conflict with Dr. Manzaneda. The applicants claim a solution for rib flare deformity, and state expressly that «the described RibXCar procedure does not offer a solution for correcting Rib Flare deformities». Citing the state of the art and proposing an improvement is standard patent practice.
The document also contains a minor inaccuracy: it places Kudzaev's work «in 2020», whereas the corresponding Russian patent is from 2017-2018 and the PRS Global Open article is from 2021.